Evidence map›Paper›PMID 18552212›Full record

ArticleBlood2008

Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression.

Heike Schmidlin, Sean A Diehl, Maho Nagasawa, Ferenc A Scheeren, Remko Schotte, Christel H Uittenbogaart, Hergen Spits, Bianca Blom

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 83 citations in OpenAlex.

  1. Tripartite motif containing 21 autoimmunity primes CD8Arthritis research & therapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Heike SchmidlinDepartment of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Sean A Diehl
Maho Nagasawa
Ferenc A Scheeren
Remko Schotte
Christel H Uittenbogaart
Hergen Spits
Bianca Blom
Academic Medical Center · NLUniversity of Amsterdam · NLUniversity of California, Los Angeles · US

Funding

HIV and Plasmacytoid dendritic cells in the thymusR01AI052002 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI UITTENBOGAART, CHRISTEL H. · 2004 to 2007
$1.5M
Role of STAT5 and Bcl-xL in human B cell survivalF32AI063846 · NIAID · UNIVERSITY OF AMSTERDAM · PI DIEHL, SEAN A. · 2005 to 2008
$151k
NIAID NIH HHS F32 AI063846NIAID NIH HHS F32-AI0638-46NIAID NIH HHS R01 AI052002NIAID NIH HHS R01-AI52002
6 · The paper itself

Abstract

The terminal differentiation of B cells into antibody-secreting plasma cells is tightly regulated by a complex network of transcription factors. Here we evaluated the role of the Ets factor Spi-B during terminal differentiation of human B cells. All mature tonsil and peripheral blood B-cell subsets expressed Spi-B, with the exception of plasma cells. Overexpression of Spi-B in CD19(+) B cells inhibited, similar to the known inhibitor BCL-6, the expression of plasma cell-associated surface markers and transcription factors as well as immunoglobulin production, ie, in vitro plasma cell differentiation. The arrest in B-cell differentiation enforced by Spi-B was independent of the transactivation domain, but dependent on the Ets-domain. By chromatin immunoprecipitation and assays using an inducible Spi-B construct BLIMP1 and XBP-1 were identified as direct target genes of Spi-B mediated repression. We propose a novel role for Spi-B in maintenance of germinal center and memory B cells by direct repression of major plasma cell factors and thereby plasma cell differentiation.

Indexed as

Binding SitesB-Lymphocyte SubsetsCell DifferentiationDNA-Binding ProteinsGene ExpressionHumansImmunoglobulinsIn Vitro TechniquesPlasma CellsPositive Regulatory Domain I-Binding Factor 1Promoter Regions, GeneticProtein Structure, TertiaryProto-Oncogene Proteins c-etsRecombinant ProteinsRegulatory Factor X Transcription FactorsRepressor ProteinsDNA-Binding ProteinsImmunoglobulinsPositive Regulatory Domain I-Binding Factor 1PRDM1 protein, humanProto-Oncogene Proteins c-etsRecombinant ProteinsRegulatory Factor X Transcription FactorsRepressor ProteinsTranscription FactorsX-Box Binding Protein 1XBP1 protein, human

Identifiers

PMID18552212
PMCPMC2518887
OpenAlexW1999104287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.